New SPAC: Drugs Made in America Acquisition II Corp. (DMIIU) Files for $500M IPO

Drugs Made in America II (NASDAQ:DMIIU) has filed for a $500 million SPAC to give the team a fresh vehicle to hunt for targets that has a larger scale and tighter terms than its predecessor. The new SPAC is offering investors one right to a 1/10 share in each unit and no overfunding, while Drugs
Read More